arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1909.09124eess.IVcs.CV
收藏

通过使用深度学习分析数字病理学图像预测胶质瘤的总生存期和分子标志物

Prediction of overall survival and molecular markers in gliomas via analysis of digital pathology images using deep learning

University of Pennsylvania(宾夕法尼亚大学);Perelman School of Medicine(佩雷尔曼医学院);COMSATS University Islamabad(COMSATS伊斯兰堡大学)

Saima Rathore, Muhammad Aksam Iftikhar, Zissimos Mourelatos

摘要:

癌症组织学揭示了疾病进展和相关的分子过程,并包含丰富的表型信息,可预测结果。在本文中,我们开发了一种基于深度学习的计算方法,用于从组织活检的显微图像中预测胶质瘤患者的总体生存率和分子亚型,反映微血管增殖,有丝分裂活性,核分裂和坏死的存在。从TCGA获得663例独特患者的全载玻片图像[IDH:333例IDH野生型,330例IDH突变体,1 p/19 q:201例1 p/19 q非共缺失,129例1 p/19 q共缺失]。提取没有伪影并且包含具有描述性组织学特征的存活肿瘤的子图像,其进一步用于训练和测试深度神经网络。网络的输出层以两种不同的方式配置:(i)输出患者风险预测的最终Cox模型层,以及(ii)具有sigmoid激活函数的最终层,以及具有二进制交叉熵损失的基于随机梯度下降的优化。使用我们的模型,生存预测和分子亚型分类都产生了有希望的结果。提出的深度学习模型的风险评分和总生存率之间的c统计量估计为0.82(p值=4.8x10-5),而IDH突变状态和1 p/19 q共缺失检测的准确率为88%(曲线下面积[AUC]=0.86)。这些发现表明,深度学习技术可以应用于显微图像,以客观,准确和综合地预测胶质瘤患者的预后。所提出的标记物可能有助于(i)将患者分层到临床试验中,(ii)选择患者进行靶向治疗,以及(iii)个性化治疗计划。

英文摘要:

Cancer histology reveals disease progression and associated molecular processes, and contains rich phenotypic information that is predictive of outcome. In this paper, we developed a computational approach based on deep learning to predict the overall survival and molecular subtypes of glioma patients from microscopic images of tissue biopsies, reflecting measures of microvascular proliferation, mitotic activity, nuclear atypia, and the presence of necrosis. Whole-slide images from 663 unique patients [IDH: 333 IDH-wildtype, 330 IDH-mutants, 1p/19q: 201 1p/19q non-codeleted, 129 1p/19q codeleted] were obtained from TCGA. Sub-images that were free of artifacts and that contained viable tumor with descriptive histologic characteristics were extracted, which were further used for training and testing a deep neural network. The output layer of the network was configured in two different ways: (i) a final Cox model layer to output a prediction of patient risk, and (ii) a final layer with sigmoid activation function, and stochastic gradient decent based optimization with binary cross-entropy loss. Both survival prediction and molecular subtype classification produced promising results using our model. The c-statistic was estimated to be 0.82 (p-value=4.8x10-5) between the risk scores of the proposed deep learning model and overall survival, while accuracies of 88% (area under the curve [AUC]=0.86) were achieved in the detection of IDH mutational status and 1p/19q codeletion. These findings suggest that the deep learning techniques can be applied to microscopic images for objective, accurate, and integrated prediction of outcome for glioma patients. The proposed marker may contribute to (i) stratification of patients into clinical trials, (ii) patient selection for targeted therapy, and (iii) personalized treatment planning.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑